NVO•benzinga•
Novo Nordisk Wins Legal Battle To Curb Unsafe Knockoff Versions Of Ozempic, Wegovy
Summary
The court ruled in favor of Novo Nordisk and the FDA, rejecting a compounding pharmacy group's attempt to stop the FDA's decision on semaglutide shortage.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 25, 2025 by benzinga